Asosiy kontentga oʻtish
Maqola

<i>In vivo</i> toxicity evaluation of two polyoxotungstates with potential antidiabetic activity using <i>Wistar</i> rats as a model system

Marko DinčićFaculty of MedicineMirjana B. ČolovićSerbiaMarija Sarić MatutinovićDepartment for Medical BiochemistryMila ĆetkovićFaculty of MedicineTamara Kravic‐StevovicFaculty of MedicineAli S. MougharbelDepartment of Life Sciences and ChemistryJasna TodorovićFaculty of MedicineSvetlana IgnjatovićDepartment for Medical BiochemistryBranimir RadosavljevićBelgradeMilan MilisavljevićFaculty of MedicineUlrich Kortz28759 BremenDanijela KrstićBelgrade
RSC Advancesjournal2020en
ABI

Annotatsiya

rats orally for 14 days in further toxicity examinations. The serum glucose concentration and biochemical parameters of kidney and liver function, as well as a histopathological analysis of kidney and liver tissues were evaluated 14 days after the polyoxotungstate administration. Both investigated compounds did not induce statistically significant alterations of the serum glucose and uric acid concentrations, as well as some of the liver function markers (serum alanine and aspartate aminotransferases, and alkaline phosphatase activities). However, the significant decrease in serum total protein and albumin concentrations and the increase in biochemical parameters of renal function - serum urea (up to 63.1%) and creatinine concentrations (up to 23.3%) were observed for both polyoxotungstates. In addition, the detected biochemical changes were in accordance with kidney and liver histhopathological analysis. Accordingly, the hepatotoxic and nephrotoxic effects of these potential antidiabetic polyoxotungstates could be considered as mild.

Hali tarjima qilinmagan

Mavzular

Identifikatorlar

Iqtiboslar va manbalar